Prolong Pharmaceuticals, LLC

États‑Unis d’Amérique

Commandez votre montre hebdomadaire Prolong Pharmaceuticals, LLC
Quantité totale PI 16
Rang # Quantité totale PI 96 291
Note d'activité PI 1,6/5.0    7
Rang # Activité PI 135 623
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

6 2
2 0
6 0
0
 
Dernier brevet 2025 - A stable hemoglobin protein comp...
Premier brevet 2007 - Polyethylene glycol erythropoiet...
Dernière marque 2005 - EPEG
Première marque 2003 - SANGUINATE

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 Invention Improved dosing regimen of pegylated hemoglobin. The present invention discloses an improved infu...
Invention Method of treating cancer using pegylated bovine hemoglobin. The present invention provides a met...
2023 Invention A stable hemoglobin protein composition. The present invention relates to a hemoglobin protein c...
Invention A stable hemoglobin protein composition. The present invention relates to a hemoglobin protein co...
Invention A stable hemoglobin protein composition
2018 Invention Hemoglobin compositions. The invention provides compositions containing hemoglobin, particularly ...
2010 Invention Hemoglobin compositions.
The invention provides compositions containing hemoglobin, pa...
2007 Invention Polyethylene glycol erythropoietin conjugates. This invention relates to novel protein conjugates...
2005 P/S Erythropoietin hormones
2003 P/S Blood substitutes for veterinary and human use